You are here:

Forthcoming Submission: oritavancin (Orbactiv)

Indication: Treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.

Drug Details

Drug Name: oritavancin (Orbactiv)
Drug Manufacturer: The Medicines Company
BNF Category:
Sub Category: 5.1 Antibacterial drugs
Submission type: Full submission
Patient Interest Group
Submission Deadline:
2/11/2015
SMC Meeting Date: 1/12/2015
Advice Due: TBC

Back